Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Tack

Showing results (31-40 of 727) with videos related to

Pageof 73
Sort By:
Alimentary Pharmacology & Therapeutics|January 7, 2012
Prucalopride for chronic intestinal pseudo-obstructionP Oustamanolakis, J Tack
Gut|September 16, 2005
Extraoesophageal manifestations of gastro-oesophageal refluxJ Poelmans, J Tack
Digestion|May 19, 2007
Gastric electrical stimulation for the treatment of gastroparesis: ready for prime time?D Ang, J Tack
Drugs of Today (Barcelona, Spain : 1998)|September 18, 2015
Naloxegol: the first orally administered, peripherally acting, mu opioid receptor antagonist, approved for the treatment of opioid-induced constipationM Corsetti, J Tack
Gut|August 21, 2001
What comes after macrolides and other motilin stimulants?J Tack, T Peeters
Digestive Diseases (Basel, Switzerland)|July 20, 2006
Promotility medications--now and in the futureG Karamanolis, J Tack
Neurogastroenterology and Motility|January 25, 2007
Dysaccommodation of the stomach: therapeutic nirvana?R Bisschops, J Tack
Neurogastroenterology and Motility|August 31, 2007
Mechanisms of serotonergic agents for treatment of gastrointestinal motility and functional bowel disordersS Kindt, J Tack
Digestive Diseases (Basel, Switzerland)|April 16, 2014
Therapeutic options for functional dyspepsiaH Vanheel, J Tack
Digestive Diseases (Basel, Switzerland)|June 23, 2012
Obesity and metabolic syndrome: an inflammatory conditionE Scarpellini, J Tack
Pageof 73

Showing results (31-40 of 727) with videos related to

Sort By:
Pageof 73
Alimentary Pharmacology & Therapeutics|January 7, 2012
Prucalopride for chronic intestinal pseudo-obstructionP Oustamanolakis, J Tack
Gut|September 16, 2005
Extraoesophageal manifestations of gastro-oesophageal refluxJ Poelmans, J Tack
Digestion|May 19, 2007
Gastric electrical stimulation for the treatment of gastroparesis: ready for prime time?D Ang, J Tack
Drugs of Today (Barcelona, Spain : 1998)|September 18, 2015
Naloxegol: the first orally administered, peripherally acting, mu opioid receptor antagonist, approved for the treatment of opioid-induced constipationM Corsetti, J Tack
Gut|August 21, 2001
What comes after macrolides and other motilin stimulants?J Tack, T Peeters
Digestive Diseases (Basel, Switzerland)|July 20, 2006
Promotility medications--now and in the futureG Karamanolis, J Tack
Neurogastroenterology and Motility|January 25, 2007
Dysaccommodation of the stomach: therapeutic nirvana?R Bisschops, J Tack
Neurogastroenterology and Motility|August 31, 2007
Mechanisms of serotonergic agents for treatment of gastrointestinal motility and functional bowel disordersS Kindt, J Tack
Digestive Diseases (Basel, Switzerland)|April 16, 2014
Therapeutic options for functional dyspepsiaH Vanheel, J Tack
Digestive Diseases (Basel, Switzerland)|June 23, 2012
Obesity and metabolic syndrome: an inflammatory conditionE Scarpellini, J Tack
Pageof 73